Saturday, December 4, 2021

Scott Bloomer

Scott Bloomer
1191 POSTS0 COMMENTS
https://www.myhealthyclick.com
Scott has been working as a professional science writer for My Healthy Click. He specializes in health care and medical-related topics, including disease, medicine, nutrition, fitness, pharmacology, wellness, public health, and patient education. Because of his educational background, he is quite conversant in the areas of science and technology as well. Though health and science are Scott’s primary areas of expertise, he enjoys learning new things and is happy to engage in independent research to prepare for a news article.

LATEST FROM AUTHOR

A new study has found that in statin users, prostate cancer screening results differ, leading to over-diagnosis, meaning men are detected with low-risk prostate cancer that does not pose a risk. The study also found that statin use did not increase the risk of prostate cancer in statin users.
A new study has found that at least one in three college-aged Americans are obese. The study found that the prevalence of obesity among people aged 18 to 25 was 33% between 2017 and 2018; it was just 6% from 1976 to 1980.
Aptevo Therapeutics, a Seattle-based biotechnology company, announced positive clinical data from its Phase Ib trial, reporting a complete remission of acute myeloid leukemia in a patient who received its experimental therapy – APVO436.
A new study by Rutgers University has found that COVID-19 at-home saliva tests could help detect or measure microscopic organisms or bacteria in the mouth. This finding could help pave the way for probiotic- or microbiome-centered therapies to treat COVID.
A new study has found that people who took selective serotonin reuptake inhibitors (SSRIs) – depression medications – may have a reduced risk of COVID severity and mortality. Of all SSRIs, fluvoxamine and fluoxetine have particularly been found effective.

Recent Posts